BioWorld: EnBiotix Inc.: Antibiotic Helpers for Resistant, Persistent Bugs

Posted by enbiotixadmin in Uncategorized | 0 comments

18.11.13

It may be a bad environment for early stage deals for most companies. But not for start-up EnBiotix Inc., according to its CEO Jeffrey Wager.  The company, which was founded in 2012, is “in discussions with multiple pharma companies” for partnering opportunities.  The reason, Wager told BioWorld Today, lies in the company’s approach. EnBiotix is not trying to develop standalone antibiotics. Instead, its technologies “could be potentiating a significant proportion of the antibiotics that are currently out there.” Full Article